Locations:
Search IconSearch

Blood Cancers

Lab equipment centrifuging blood. Concept image of a blood test.3d rendering.
February 3, 2022/Cancer/Blood Cancers

Newly Identified Risk Factors Help Predict How Aplastic Anemia Can Become Malignant

Study reveals characteristics that may spark the development of myelodysplastic syndrome and acute myeloid leukemia

Chemotherapy
February 1, 2022/Cancer/Blood Cancers

New Drug Combination Can Extend the Lives of Older Patients with Ph+ Acute Lymphoblastic Leukemia

Novel regimen may help overcome the shortcomings of traditional chemotherapy in geriatric population

Human liver tissue with Amyloidosis under a microscope.
January 25, 2022/Cancer/Blood Cancers

Addition of CAEL-101 to Anti-Plasma Cell Dyscrasia Therapy May Have Long-Term Benefits in Patients with AL Amyloidosis

Follow-up study confirms safety and tolerability of new treatment protocol

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Photomicrograph of Acute Myeloblastic Leukemia (AML), a cancer of white blood cell
December 28, 2021/Cancer/Blood Cancers

Uproleselan May Improve Remission, Reduce Side Effects in Patients with Acute Myeloid Leukemia

Study finds drug safe and effective when combined with chemotherapy

Mukherjee CQD 654×450
December 23, 2021/Cancer/Blood Cancers

Novel Program Optimizes Diagnostic and Treatment Strategies for Rare Diseases

Multidisciplinary team tackles the management of 84 uncommon cancers and blood disorders

Chimeric antigen receptor (CAR) therapy,
December 14, 2021/Cancer/Blood Cancers

Biomarkers Predict Outcomes of CAR T-Cell Therapy in Patients with Diffuse Large B-Cell Lymphoma

Treatment may be a lifesaving option for patients with relapsed or refractory disease

BackPage 5 of 6Next

Advertisement

Ad